Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%.
Latest Information Update: 26 Jul 2023
At a glance
- Drugs Dexamethasone (Primary) ; Loteprednol etabonate; Moxifloxacin; Prednisolone acetate; Trimethoprim/polymixin B
- Indications Ocular inflammation; Ocular pain; Postoperative inflammation; Postoperative pain
- Focus Therapeutic Use
- 21 Jul 2023 Status changed from recruiting to completed.
- 15 Nov 2022 Planned End Date changed from 1 Jun 2022 to 1 Jan 2023.
- 15 Nov 2022 Planned primary completion date changed from 1 Mar 2022 to 1 Jan 2023.